Evidence map›Paper›PMID 38854755›Full record

ArticleBioinformation2024

Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update.

Samer Mohammed Hassan Alqarni, Mohammed Saad Alamri, Peter Natesan Pushparaj, Irfan Rather, Zafar Iqbal, Muhammad Asif, Mahmood Rasool

Abstract read
In one paragraph

Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samer Mohammed Hassan AlqarniDepartment of Biological Science, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohammed Saad AlamriDepartment of Biological Science, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Peter Natesan PushparajCenter of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Irfan RatherDepartment of Biological Science, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Zafar IqbalKing Saud Bin Abdul Aziz University, King Abdullah International Medical Research Center, Al Ahsa, Saudi Arabia.
Muhammad AsifDepartment of Biotechnology, & ORIC, Balochistan University of Information Technology, Engineering & Management Sciences, Quetta, Pakistan.
Mahmood RasoolCenter of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the second most common cancer in the world. In Saudi Arabia, CRC is the most common cancer in males and the third most common in females, and its incidence rate is rising as the country continues to develop. However, the country does not have a national CRC screening program for CRC. This review aims to review recent studies that have attempted to address and rectify this issue and discern the most notable and prevalent barriers. Despite these efforts, guidelines are still lacking. Two prospective studies have been conducted in recent years, one of which was a national pilot screening program conducted by the Ministry of Health (MOH). While both had a similar number of participants, the colonoscopy rate for patients with a positive fecal immunochemical test (FIT) in the MOH program was only 20% compared to 75.8% in the Al-Kharj program. Awareness of the Saudi population regarding CRC and its screening appears to be insufficient. The most common barriers to patients' willingness to undergo screening were embarrassment, fear, and pain. Barriers to physicians are mostly related to factors outside their hands, such as lack of equipment and time. We conclude that efforts should be made to establish a national screening program and improve awareness of the population and physicians.

Indexed as

BarriersColorectal CancerFecal Immunochemical TestIncidentsScreeningTreatment

Identifiers

PMID38854755
PMCPMC11161890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.